SCHEMBL5175867

SCHEMBL5175867

O=C1C=C(O)C(=O)c2c(O)cccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.72
KDM4E B2RXH2 4/20 0.72
RECQL P46063 4/20 0.72
KMT2A Q03164 3/20 0.72
POLB P06746 2/20 0.72
USP2 O75604 2/20 0.72
CTDSP1 Q9GZU7 1/20 0.72
P4HB P07237 11/20 0.68
AURKA O14965 2/20 0.68
AURKB Q96GD4 2/20 0.68
ATM Q13315 1/20 0.67
MAOA P21397 2/20 0.63
BACE1 P56817 2/20 0.62
ALDH1A1 P00352 3/20 0.61
HPGD P15428 3/20 0.61
ALOX15 P16050 3/20 0.61
MAPK1 P28482 3/20 0.61
HSD17B10 Q99714 3/20 0.61
TDP1 Q9NUW8 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29728494 1.00 MAPT (0.72) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL109904 0.84 MAPT (0.72) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL29405399 0.84 MAPT (0.72) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL18992256 0.81 AURKA (0.54) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL19027708 0.81 AURKA (0.54) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL24389157 0.81 P4HB (0.64) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL868197 0.81 P4HB (1.00) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL18992112 0.81 ADORA2A (0.53) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL2957896 0.81 AURKA (1.00) MAPTKDM4ERECQLKMT2APOLB
SCHEMBL5806124 0.81 MAPT (0.49) MAPTKDM4ERECQLKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 EP claimed
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative L'OREAL S.A. 2007-06-14 US claimed
EP-1434552-A1 METHOD FOR DYEING KERATINOUS FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 EP claimed
US-6635090-B1 Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative L'OREAL, S.A. (FR) 2003-10-21 US claimed
WO-2003030841-A1 METHOD FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
US-6458168-B1 Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative L'OREAL S.A. (FR) 2002-10-01 US claimed
US-6451067-B1 HAIR DYE MIXTURE L'OREAL S.A. (FR) 2002-09-17 US claimed
US-5859066-A APPLYING AN EFFECTIVE AMOUNT A 1,4-NAPHTHOQUINONE TO THE AFFECTED AREA OF THE SKIN RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-01-12 US claimed
EP-0498707-B1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent OREAL (FR) 1995-08-02 EP claimed
EP-0498707-A1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent L'OREAL (FR) 1992-08-12 EP claimed
US-4888026-A HAIR DYES; OXIDATION RESISTANCE L'OREAL (FR) 1989-12-19 US claimed
EP-3843696-B1 PROCESS AND COMPOSITION FOR COLORING KERATIN FIBERS OREAL (FR) 2025-04-09 EP disclosed
EP-3280402-B1 TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING BIOMENDICS LLC (US) 2024-06-05 EP disclosed
CN-113164346-B Composition for keratin fibres comprising a direct dye 莱雅公司 2024-04-16 CN disclosed
CN-112601515-B Method and composition for coloring keratin fibers 莱雅公司 2024-04-05 CN disclosed
US-5259849-A Solvent, nonionic surfactant L'OREAL (FR) 1993-11-09 US disclosed
EP-0498707-A1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent L'OREAL (FR) 1992-08-12 EP disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
US-4888026-A HAIR DYES; OXIDATION RESISTANCE L'OREAL (FR) 1989-12-19 US disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative KRT18, NDUFB5, NDUFB7 MAPT 685/4885KDM4E 440/4885RECQL 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.